. hummingbirdbio enters into an agreement with Mycenax Biotech for the production of material for the Phase I clinical trial of its HMBD002 program httpow.lyLbQq50ywq8LÂpic.twitter.com8lsuDqCA2K
. @hummingbirdbio enters into an agreement with Mycenax Biotech for the production of material for the Phase I clinical trial of its HMBD-002 program: http://ow.ly/LbQq50ywq8L pic.twitter.com/8lsuDqCA2K
More From BioPortfolio on ". @hummingbirdbio enters into an agreement with Mycenax Biotech for the production of material for the Phase I clinical trial of its HMBD-002 program: http://ow.ly/LbQq50ywq8L pic.twitter.com/8lsuDqCA2K"